Asset

BENZHYDROCODONE HYDROCHLORIDE

Zevra Therapeutics Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 208653NDAZEVRA THERAPEUTICS

Marketed products (3)

  • APADAZ
  • APADAZ
  • APADAZ